Few people realise that the Emergency Use Authorisation (EUA)of the Pfizer-BioNTech Covid-19 Vaccine/BNT 162b2 was granted on the efficacy data of 170 patients. The 162 who received a placebo and 8 patients who were vaccinated formed the basis of the 95 per cent efficacy claims.
There has not been much discussion of these patients.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk